NUCLEIC ACID CONSTRUCT BASED ON CRE-LOXP AND CRISPR AND USE THEREOF

    公开(公告)号:US20250160308A1

    公开(公告)日:2025-05-22

    申请号:US18840525

    申请日:2023-05-17

    Abstract: Provided are a nucleic acid construct based on a Cre-LoxP recombination system and a CRISPR gene editing system and use thereof. The Cre-LoxP recombination system comprises a Cre enzyme and a LoxP nucleic acid combination. The LoxP nucleic acid combination comprises TATA-Lox71 and TATA-LoxTC9 sequences, which can only be recombined once under the catalysis of the Cre enzyme. The nucleic acid construct carries an inert “stuffer sequence” with a certain length. The nucleic acid construct can express a plurality of sgRNAs in a low bias manner in vivo, but a same cell can only express one sgRNA, thereby efficiently generating mosaicism whose utilities include accurate and sensitive in-situ CRISPR gene screening and rapid, cost-effective preparation of a single-gene knockout line.

Patent Agency Ranking